Clinical utility of change in nonalcoholic fatty liver disease activity score and change in fibrosis in NAFLD.

Tamaki N, Munaganuru N, Jung J, Yonan AQ, Bettencourt R, Ajmera V, Valasek MA, Behling C, Loomba R. Clin Gastroenterol Hepatol. 2020 Nov 3:S1542-3565(20)31518-4. doi: 10.1016/j.cgh.2020.11.005.